About this trial
This clinical trial aims to develop and test a prototype immersive gamification technology system (ImGTS) among healthy volunteers and to determine its acceptability, safety, and usability in a healthy population. The main question it aims to answer is:
Does ImGTS provide an acceptable, safe, and usable therapeutic modality for patients with Parkinson's Disease? Researchers will compare a head-mounted display (HMD) system and a semi cave automatic virtual environment (semi-CAVE) system to see if they are acceptable, safe, and usable as therapy for PD.
Participants will be will undergoing their assigned ImGTS intervention for four sessions (twice a week for two weeks) supervised by a trained therapist. Afterwards, they will be interviewed based on specific questionnaires used to check for acceptability, safety, and usability.
Eligibility criteria
Qualifiers
Aged 50 to 70 years old
Able to understand Filipino and English
Montreal Cognitive Assessment - Philippines (MOCA-P) score >27
Timed Up and Go <10 seconds
Disqualifiers
Previously diagnosed with any neurologic condition
With any form of aphasia
Previously diagnosed with a psychiatric disorder
Previously diagnosed with seizures or epilepsy
Trial design
Treatments tested in this trial
- VR-HMD
- AR-HMD
- semi-CAVE
Treatment groups
Sponsors and collaborators
Augmented eXperience E-health Laboratory
Lead sponsor
Department of Science and Technology (DOST) - Philippine Council for Health Research and Development (PCHRD)
Collaborator